nasdaq

Horizon Pharma and Sanofi Announce FDA Approval of DUEXIS(R) Commercial Manufacturing Facility

by Symptom Advice on November 14, 2011

KALBITOR® (ecallantide) Data in HAE Presented at the American College of Allergy, Asthma and Immunology Annual Meeting

by Symptom Advice on November 10, 2011

Meridian Bioscience bets big on illumigene testing platform

by Symptom Advice on October 29, 2011

Stocks on watch: IPXL, UPI, SAAS

by Symptom Advice on April 14, 2011

Repros(R) Therapeutics Commences Dosing Third Cohort in Low Dose Proellex(R) Study

by Symptom Advice on March 17, 2011

NPS Pharmaceuticals Completes Patient Randomization in Phase 3 REPLACE Study of NPSP558 in Hypoparathyroidism – News Press Release

by Symptom Advice on March 15, 2011

Immunomedics Reports Targeted Therapy for Advanced Pancreatic Cancer Improves Survival

by Symptom Advice on February 2, 2011

U.S. FDA and Health Canada Grant Priority Reviews for Telaprevir for the Treatment of Hepatitis C

by Symptom Advice on January 22, 2011

Walgreens Announces Free Blood Pressure Testing at Stores and Take Care Clinics Throughout the U.S.

by Symptom Advice on January 15, 2011

Alkermes Provides Update on Advancing Product Portfolio and Outlines Business Goals for 2011

by Symptom Advice on January 10, 2011

← Previous Entries